Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Prepaid Assets: 2021-2025

Historic Prepaid Assets for InMed Pharmaceuticals (INM) over the last 4 years, with Sep 2025 value amounting to $191,755.

  • InMed Pharmaceuticals' Prepaid Assets rose 28.80% to $191,755 in Q3 2025 from the same period last year, while for Sep 2025 it was $191,755, marking a year-over-year increase of 28.80%. This contributed to the annual value of $321,747 for FY2025, which is 32.65% down from last year.
  • As of Q3 2025, InMed Pharmaceuticals' Prepaid Assets stood at $191,755, which was down 40.40% from $321,747 recorded in Q2 2025.
  • InMed Pharmaceuticals' 5-year Prepaid Assets high stood at $1.3 million for Q1 2022, and its period low was $140,512 during Q4 2021.
  • Its 3-year average for Prepaid Assets is $530,173, with a median of $498,033 in 2023.
  • In the last 5 years, InMed Pharmaceuticals' Prepaid Assets surged by 488.51% in 2022 and then slumped by 50.14% in 2025.
  • Quarterly analysis of 5 years shows InMed Pharmaceuticals' Prepaid Assets stood at $140,512 in 2021, then spiked by 488.51% to $826,931 in 2022, then soared by 34.59% to $1.1 million in 2023, then tumbled by 42.14% to $643,986 in 2024, then grew by 28.80% to $191,755 in 2025.
  • Its Prepaid Assets was $191,755 in Q3 2025, compared to $321,747 in Q2 2025 and $507,872 in Q1 2025.